Viral hepatitis in HIV infection

被引：221

作者：

Koziel, Margaret James

Peters, Marion G.

机构：

[1] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA

[2] Harvard Univ, Sch Med, Boston, MA USA

[3] Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2007年 / 356卷 / 14期

关键词：

D O I：

10.1056/NEJMra065142

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1445 / 1454

页数：10

共 99 条

[1] Epidemiology of viral hepatitis and HIV co-infection [J].

Alter, MJ .

JOURNAL OF HEPATOLOGY, 2006, 44 :S6-S9

[2] Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons [J].

Alvarez, D. ;

Dieterich, D. T. ;

Brau, N. ;

Moorehead, L. ;

Ball, L. ;

Sulkowski, M. S. .

JOURNAL OF VIRAL HEPATITIS, 2006, 13 (10) :683-689

[3] Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase [J].

Angus, P ;

Vaughan, R ;

Xiong, S ;

Yang, HL ;

Delaney, W ;

Gibbs, C ;

Brosgart, C ;

Colledge, D ;

Edwards, R ;

Ayres, A ;

Bartholomeusz, A ;

Locarnini, S .

GASTROENTEROLOGY, 2003, 125 (02) :292-297

[4] Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection [J].

Aranzabal, L ;

Casado, JL ;

Moya, J ;

Quereda, C ;

Diz, S ;

Moreno, A ;

Moreno, L ;

Antela, A ;

Perez-Elías, MJ ;

Dronda, F ;

Marín, A ;

Hernandez-Ranz, F ;

Moreno, A ;

Moreno, S .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (04) :588-593

[5] Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy [J].

Bani-Sadr, F ;

Carrat, F ;

Pol, S ;

Hor, R ;

Rosenthal, E ;

Goujard, C ;

Morand, P ;

Lunel-Fabiani, F ;

Salmon-Ceron, D ;

Piroth, L ;

Pialoux, G ;

Bentata, M ;

Cacoub, P ;

Perronne, C .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (01) :47-52

[6] Treatment algorithm for chronic hepatitis B in HIV-infected patients [J].

Benhamou, Y .

JOURNAL OF HEPATOLOGY, 2006, 44 :S90-S94

[7] Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1 [J].

Benhamou, Y ;

Thibault, V ;

Vig, P ;

Calvez, V ;

Marcelin, AG ;

Fievet, MN ;

Currie, G ;

Chang, CG ;

Biao, L ;

Xiong, S ;

Brosgart, C ;

Poynard, T .

JOURNAL OF HEPATOLOGY, 2006, 44 (01) :62-67

[8] Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients [J].

Benhamou, Y ;

Bochet, M ;

Thibault, V ;

Di Martino, V ;

Caumes, E ;

Bricaire, F ;

Opolon, P ;

Katlama, C ;

Poynard, T .

HEPATOLOGY, 1999, 30 (05) :1302-1306

[9] Antiretroviral therapy and HIV/hepatitis B virus coinfection [J].

Benhamou, Y .

CLINICAL INFECTIOUS DISEASES, 2004, 38 :S98-S103

[10] Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort [J].

Braitstein, P ;

Justice, A ;

Bangsberg, DR ;

Yip, B ;

Alfonso, V ;

Schechter, MT ;

Hogg, RS ;

Montaner, JSG .

AIDS, 2006, 20 (03) :323-331

← 1 2 3 4 5 6 7 8 9 10 →